You just read:

Daiichi Sankyo, Inc. Initiates ENTRUST-AF PCI Study Investigating Once-Daily SAVAYSA® (edoxaban) in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stenting

News provided by

Daiichi Sankyo, Inc.

Mar 06, 2017, 08:00 ET